Acute teaching trust starts clinical trial of Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing in UK
Nottingham University Hospitals NHS Trust is commencing recruitment for the clinical trial of the Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing.
The conditions are Brain Tumors, Quality of Life, Brain Tumor, Pediatric.
A new clinical trial is recruiting patients in the following locations: United Kingdom.
The trial officially began on the February 1, 2021 and is planned to complete on January 2023.
Survivors of childhood brain tumours have the poorest health-related quality of life of all cancer survivors due to the multiple physical and psychological sequelae of brain tumours and their treatment. Remotely delivered Acceptance and Commitment Therapy (ACT) may be a suitable and accessible psychological intervention to support young people who have survived brain tumours.
This study aims to assess the feasibility and acceptability of remotely delivered ACT to improve quality of life among young brain tumour survivors.
The study will provide an initial assessment of the value of remotely delivered ACT in supporting recovery and coping for young people after brain tumour treatment.
The population that can be enrolled into this study includes:
- Aged 11-to-24 years at the time of randomization
- Received treatment for a brain tumour at a participating Principle Treatment Centre
- Active brain tumour treatment is complete and their condition stable for at least six-months
- Have sufficient cognitive ability to engage with ACT sessions as judged by the clinician at baseline assessment
University of Nottingham, University Hospitals Bristol NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, University of Exeter, Great Ormond Street Hospital for Children NHS Foundation Trust, University of Surrey, Newcastle University, University of Bristol and DNA-v International are the collaborators in this clinical trial.
Nottingham University Hospitals NHS Trust (NUH) is one of England's largest acute teaching trusts. It was established on 1 April 2006 following the merger of Nottingham City Hospital and the Queen's Medical Centre NHS Trusts. They provide acute and specialist services to 2.5 million people within Nottingham and surrounding communities at the Queen’s Medical Centre (QMC) and the City Hospital campuses, as well as specialist services for a further 3-4 million people from across the region.
The link to the complete study profile: https://ichgcp.net/clinical-trials-registry/NCT04722237
